These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9768754)

  • 1. Rapid death and regeneration of NKT cells in anti-CD3epsilon- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis.
    Eberl G; MacDonald HR
    Immunity; 1998 Sep; 9(3):345-53. PubMed ID: 9768754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18.
    Baxevanis CN; Gritzapis AD; Papamichail M
    J Immunol; 2003 Sep; 171(6):2953-9. PubMed ID: 12960319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK1.1+ cell depletion in vivo fails to prevent protection against infection with the murine nematode parasite Trichuris muris.
    Koyama K
    Parasite Immunol; 2002; 24(11-12):527-33. PubMed ID: 12694603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of NKT cell differentiation by tissue-specific microenvironments.
    Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
    J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 prevents T cell-mediated hepatitis via inhibition of NKT cells in CD4+ T cell- and STAT3-dependent manners.
    Sun R; Tian Z; Kulkarni S; Gao B
    J Immunol; 2004 May; 172(9):5648-55. PubMed ID: 15100309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production.
    Baker J; Verneris MR; Ito M; Shizuru JA; Negrin RS
    Blood; 2001 May; 97(10):2923-31. PubMed ID: 11342413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage relationships and differentiation of natural killer (NK) T cells: intrathymic selection and interleukin (IL)-4 production in the absence of NKR-P1 and Ly49 molecules.
    Lantz O; Sharara LI; Tilloy F; Andersson A; DiSanto JP
    J Exp Med; 1997 Apr; 185(8):1395-401. PubMed ID: 9126920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous activation of natural killer T cells and autoantibody production in mice injected with denatured syngeneic liver tissue.
    Naito T; Kawamura T; Bannai M; Kosaka T; Kameyama H; Shimamura K; Hoshi O; Ushiki T; Hatakeyama K; Abo T
    Clin Exp Immunol; 2002 Sep; 129(3):397-404. PubMed ID: 12197879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of NK cells and extrathymic T cells generated in the liver of irradiated mice with a liver shield.
    Halder RC; Seki S; Weerasinghe A; Kawamura T; Watanabe H; Abo T
    Clin Exp Immunol; 1998 Dec; 114(3):434-47. PubMed ID: 9844055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytometric and functional analyses of NK and NKT cell deficiencies in NOD mice.
    Poulton LD; Smyth MJ; Hawke CG; Silveira P; Shepherd D; Naidenko OV; Godfrey DI; Baxter AG
    Int Immunol; 2001 Jul; 13(7):887-96. PubMed ID: 11431419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting edge: LFA-1 is required for liver NK1.1+TCR alpha beta+ cell development: evidence that liver NK1.1+TCR alpha beta+ cells originate from multiple pathways.
    Ohteki T; Maki C; Koyasu S; Mak TW; Ohashi PS
    J Immunol; 1999 Apr; 162(7):3753-6. PubMed ID: 10201888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of NK but not NKT cells in acute rejection of parental bone marrow cells in F1 hybrid mice.
    Suzue K; Reinherz EL; Koyasu S
    Eur J Immunol; 2001 Nov; 31(11):3147-52. PubMed ID: 11745331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of NK1.1+ T cells in the rejection of lpr alphabetaT cells when bone marrow cells of lpr mice are transplanted into B6 mice.
    Tsukahara A; Kawamura H; Iiai T; Moroda T; Suzuki S; Tada T; Minagawa M; Musha N; Hatakeyama K; Abo T
    Microbiol Immunol; 1998; 42(6):447-56. PubMed ID: 9688079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells.
    Tomura M; Zhou XY; Maruo S; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Tanimoto T; Kurimoto M; Fujiwara H
    J Immunol; 1998 May; 160(10):4738-46. PubMed ID: 9590219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
    Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
    Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of mouse liver natural killer cells and NK1.1(+) T cells by bacterial superantigen-primed Kupffer cells.
    Dobashi H; Seki S; Habu Y; Ohkawa T; Takeshita S; Hiraide H; Sekine I
    Hepatology; 1999 Aug; 30(2):430-6. PubMed ID: 10421651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.